# Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease

> **NCT01963845** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 50 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01963845
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963845, "Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01963845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*